Here you can find aHUS publications and data related to C5-inhibitors, Ravulizumab, and Relapse Risk.
Disclaimer: Please note that this bibliography was created using specific search criteria, visible in the respective search function. Due to selected filters, not all relevant literature may be included. Publications on off-label use of Eculizumab and Ravulizumab were excluded. The literature shown is limited to those identified by these criteria, which are regularly reviewed. For a comprehensive evaluation or specific questions, further research using tailored criteria is recommended.
Disclaimer: Please note that this bibliography was created using specific search criteria, visible in the respective search function. Due to selected filters, not all relevant literature may be included. Publications on off-label use of Eculizumab and Ravulizumab were excluded. The literature shown is limited to those identified by these criteria, which are regularly reviewed. For a comprehensive evaluation or specific questions, further research using tailored criteria is recommended.
With one click, you can download the informational material about the vaccination, the vaccination certificate, the cost approval, and our Alexion order form.
If you have any questions, please contact your Regional Account Manager or Medical Advisor.CONTACT US
Austria: https://unifyrare.com/de-at/kontaktieren-sie-uns AustriaMedicalTeamMICC@alexion.com Switzerland: https://unifyrare.com/de-ch/kontaktieren-sie-uns SwitzerlandMedicalTeamMICC@alexion.com